Ausgabe 5/2016
Inhalt (9 Artikel)
MicroRNA Exert Macro Effects on Cancer Bone Metastasis
Scott R. Baier, Yihong Wan
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease
Christina J. Turner, Claire M. Edwards
Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives
Cemre Robinson, Michael T. Collins, Alison M. Boyce
Cortical Bone Porosity: What Is It, Why Is It Important, and How Can We Detect It?
D. M. L. Cooper, C. E. Kawalilak, K. Harrison, B. D. Johnston, J. D. Johnston
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease
S. Binks, R. Dobson
Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?
Stuart J. Warden, Robyn K. Fuchs
Osteonecrosis of the Jaw—a Bone Site-Specific Effect of Bisphosphonates
Jenny A. F. Vermeer, Greetje A. P. Renders, Vincent Everts
Advances in Controlled Drug Delivery for Treatment of Osteoporosis
T. A. Asafo-Adjei, A. J. Chen, A. Najarzadeh, D. A. Puleo
Nanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences
Donglei Wei, Jinsuh Jung, Huilin Yang, David A. Stout, Lei Yang